Cargando…
Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958524/ http://dx.doi.org/10.2147/CE.S63964 |
Ejemplares similares
-
Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014) -
Eptifibatide: The evidence for its role in the management of acute coronary syndromes
por: Shah, Ibrahim, et al.
Publicado: (2010) -
Corrigendum to: Clinical governance of patients with acute coronary syndromes
Publicado: (2022) -
Corrigendum to: “2019 guidelines for the diagnosis and management of chronic coronary syndromes”: congratulations and tribulations
Publicado: (2021) -
Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017)